(Q34625037)

3 August 2017

1 reference

title

Stem cell transplantation in multiple sclerosis: multiple choices and multiple challenges (English)

1 reference

stem cell transplantation

3 August 2017

0 references

1 reference

R Q Hintzen

1

1 reference

3 August 2017

publication date

1 April 2002

1 reference

Multiple Sclerosis Journal

3 August 2017

published in

1 reference

3 August 2017

volume

8

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

155-160

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS789OA

3 August 2017

1 reference

Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS789OA

Axonal pathology in multiple sclerosis: relationship to neurologic disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS789OA

Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS789OA

Hematopoietic stem cell transplantation for autoimmune disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS789OA

Autologous stem cell transplantation in progressive multiple sclerosis--an interim analysis of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS789OA

Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS789OA

Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation. BMT-MS Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS789OA

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS789OA

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS789OA

Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS789OA

High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS789OA

The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS789OA

Embryonic stem cell-derived glial precursors: a source of myelinating transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS789OA

Bone marrow transplantation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS789OA

Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS789OA

10.1191/1352458502MS789OA

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference